葵花药业：关于获得药物临床试验批准通知书的公告

Core Viewpoint - The announcement indicates that the company has received approval from the National Medical Products Administration for clinical trials of a pediatric medication aimed at treating acute bronchitis in children [1] Group 1 - The company is a fully-owned subsidiary of Kew Flower Pharmaceutical Group Co., Ltd. [1] - The approved product is a cough syrup specifically designed for children, named "Pediatric Lung Heat Cough and Wheezing Oral Solution" [1] - The clinical trial will focus on the treatment of acute bronchitis in children [1]